Lilly To Bolster IBD Pipeline With $3.2bn Morphic Bid

 
• By Joseph Haas
  
Eli Lilly logo sign atop Lilly Biotechnology Center campus
Lilly will add oral integrins to its pipeline via $3.2bn bid for Morphic • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business